Evaluating Medicare’s RAPID Pathway: Advancements for Adults and Pediatric Gaps

The Centers for Medicare & Medicaid Services recently introduced the Rapid Assessment and Pathway for Innovation and Development (RAPID) to accelerate the transition of medical devices from clinical trials to reimbursement for adults. This milestone addresses significant regulatory hurdles and is widely considered a major advancement in streamlining modern medical innovation. However, the introduction of this pathway has highlighted a growing disparity in the healthcare landscape. While adult patient advocacy groups and industry leaders celebrate this progress, the pediatric sector remains conspicuously absent from these improvements. The pediatric medical device industry faces unique regulatory and market challenges that have historically stalled development, leading to a 'valley of death' that the new RAPID pathway has yet to bridge. Experts warn that without equivalent policy initiatives specifically tailored to pediatric needs, children will continue to experience significant delays in accessing life-saving technology. The disparity underscores a critical need for policymakers to expand innovation frameworks to ensure equitable healthcare access across all age demographics, ensuring that pediatric patients are no longer left behind in the pursuit of technological progress.